Head Diagnostics is a Ireland-based startup with a focus on developing groundbreaking technology and a handheld medical device tailored for the diagnosis and monitoring of Parkinson's Disease (PD) and concussion (mTBI). The company's mission is to offer a swift assessment tool that aids clinicians in objectively diagnosing brain diseases and impairments. This initiative has attracted the attention of investors, with PharmStars providing Non-Equity Assistance investment in 12 July 2022. The startup, established in 2018, operates within the Life Sciences and Medical Devices sectors, and its slogan emphasizes the development of new medical devices for Parkinson's Disease diagnosis and monitoring, along with medical devices for neuro disease and brain injury.
No recent news or press coverage available for Head Diagnostics.